OR WAIT null SECS
© 2021 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2021 MJH Life Sciences™ and Formulary Watch. All rights reserved.
August 04, 2021
The FDA is expected to make a decision on this indication by December 1, 2021.
August 03, 2021
The therapy had received accelerated approval in 2011 but a phase 3 confirmatory trial found it did not meet the end point of progression-free survival.
August 02, 2021
The sickle cell disease therapy will now be on the Preferred Drug List.
This is the first new approval for lupus in a decade.
The agent targets excessive daytime sleepiness.
Pharmacies will need to obtain pre-dispense authorization for clozapine.
July 30, 2021
Some fatal cases of ketoacidosis have occurred, and high-risk patients should be monitored when starting treatment.
July 29, 2021
The FDA is requesting an additional study to demonstrate tenapanor lowers serum phosphorus.
July 28, 2021
The findings were similar in people with or without diabetes.
July 26, 2021
A substantial discount would be needed to meet cost-effectiveness thresholds.